How perfusion and ECMO teams can use IPA’s device safety resource to review FDA recalls, interpret MAUDE reports, and turn alerts into documented action.
On May 8, 2024, the FDA warned healthcare providers about ongoing safety concerns with Getinge/Maquet cardiovascular devices, specifically the Cardiosave Hybrid and Rescue IABP
PerfusionGPT AssistantEducation · Research · Global cardiac care
Educational information only. Follow your institution’s clinical protocols. Please do not share patient information. Document search is being connected.
This site is protected by reCAPTCHA.
IPA COMMUNITY POLL
What is the biggest challenge facing your perfusion team today?